Davis Polk

Matthew Yeowart

Deals
4
Latest
Jun 2026

Firm

Deals by year
Matthew Yeowart: deals by year0123420252026 YTD: 4 M&A42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Matthew Yeowart was named on, most recent first
Jun 2026 SAGA Diagnostics –RocheAcquisitionLegal adviser to Roche (acquirer)Announced595.0Diagnostics+1Roche acquisition of SAGA Diagnostics
May 2026 Mirantis –IRENAcquisitionLegal adviser to IREN (acquirer)Completed625.0Software+1IREN acquisition of Mirantis
Mar 2026 BVNK –MastercardAcquisitionLegal adviser to Mastercard (acquirer)Completed1,800.0Payments Infrastructure+1Mastercard acquisition of BVNK
Jan 2026 AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 AbelZetaAstraZenecaAsset saleLegal adviser to AbelZeta (target)Announced630.0Biotech+2AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031

Deals where Matthew Yeowart is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.